This report was recently updated on July 20 2024 with the latest and most recent
market numbers
Global Precision Medicine Software Market Size, Trends & Analysis - Forecasts to 2029 By Delivery Mode (On-premise and Cloud-based), By Application (Oncology, Pharmacogenomics, Rare Diseases, and Others) By End User (Healthcare Providers, Research Centers & Government Institutes, and Pharmaceutical & Biotechnology Companies), and By Region (North America, Asia Pacific, Central & South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global precision medicine software market is analyzed to grow at a CAGR of 13.3% during the forecast period from 2024 to 2029. Precision medicine software integrates clinical and molecular data to offer valuable insights for determining the best treatment path.
The market is mainly driven by technological advancements and increasing demand for personalized healthcare solutions. Technological innovations such as big data analytics, artificial intelligence, and genomic sequencing are enhancing the capabilities of precision medicine software, enabling more accurate patient diagnosis and treatment recommendations. Moreover, the growing preference for tailored healthcare solutions among patients and healthcare providers drives the adoption of precision medicine software. Precision medicine software has the potential to revolutionize preventive healthcare by enabling early detection of diseases, identification of individuals at high risk, and personalized interventions to prevent or manage health conditions. This presents a lucrative opportunity for software developers and healthcare providers to tap into the growing demand for preventive healthcare solutions.
The high cost associated with precision medicine software implementation and maintenance is a significant restraint in this market. The initial investment required for infrastructure setup, software customization, and staff training can be substantial, posing a barrier to adoption for some healthcare organizations and individuals.
Based on delivery mode, the market is segmented into on-premise and cloud-based. The on-premise segment is expected to hold the largest share of the market during the forecast period. It can be attributed to data security concerns and existing infrastructure preferences among healthcare organizations. These models enable end users to utilize solutions from various providers and empower buyers to determine the timing of software upgrades.
The cloud-based segment is projected to grow fastest during the forecast period. This growth is fueled by benefits such as scalability, flexibility, and cost-effectiveness offered by cloud-based solutions. Additionally, the increasing adoption of cloud computing across various industries, including healthcare, drives the demand for cloud-based precision medicine software. As a result, healthcare providers are increasingly transitioning towards cloud-based solutions to leverage these advantages and enhance their precision medicine capabilities.
Based on application, the market is segmented into oncology, pharmacogenomics, rare diseases, and others. The oncology segment is expected to hold the largest share of the market during the forecast period. This is due to the pressing need for precise and personalized treatment options in cancer care. Precision medicine software is crucial in analyzing genomic data and tailoring therapies to individual patients, leading to more effective treatment outcomes in oncology. As cancer continues to be a major global health concern, the demand for precision medicine solutions in oncology remains high.
The pharmacogenomics segment is projected to grow fastest during the forecast period. Pharmacogenomics utilizes genetic information to predict individual medication responses, optimizing treatment efficacy and reducing adverse reactions. As personalized medicine gains traction, healthcare providers increasingly recognize the value of pharmacogenomics in tailoring drug regimens to patients' genetic profiles. This growing awareness and adoption are driving the rapid growth of the pharmacogenomics segment in the precision medicine software market.
Based on end user, the market is segmented into healthcare providers, research centers & government institutes, and pharmaceutical & biotechnology companies. The healthcare providers segment is expected to hold the largest share of the market during the forecast period. Healthcare providers rely on these solutions for personalized diagnosis, treatment planning, and monitoring patient progress. With a growing emphasis on patient-centered care and the increasing adoption of precision medicine approaches in clinical practice, healthcare providers are driving the demand for precision medicine software solutions, thus dominating the market.
The pharmaceutical & biotechnology companies segment is projected to grow fastest during the forecast period. These companies are leveraging precision medicine software to accelerate drug discovery, develop targeted therapies, and conduct clinical trials more efficiently. Additionally, partnerships between pharmaceutical firms and software providers are driving innovation in precision medicine solutions, further fueling the growth of this segment within the market.
North America is analyzed to be the largest region in the global precision medicine software market during the forecast period. North America dominates the market due to factors like advanced healthcare infrastructure, significant investments in healthcare technology, and a high adoption rate of precision medicine approaches. Moreover, the presence of leading pharmaceutical and biotechnology companies and extensive research activities in the region further contribute to its leadership in this market.
Asia Pacific is analyzed to be the fastest-growing region in the precision medicine software market during the forecast period. Increased healthcare spending in countries like China, India, and Japan fuels demand for advanced healthcare solutions. Improvements in healthcare infrastructure support the implementation of precision medicine solutions. The rising incidence of chronic diseases in the region underscores the need for personalized treatment solutions, boosting the demand for precision medicine software. Collaborations between academic institutions and industry players accelerate research and development in precision medicine.
Synapse, Inc., Allscripts Healthcare Solutions, Inc., Roche Holdings, Inc., Fabric Genomics, Inc., Sophia Genetics SA, PierianDx, Inc., Qiagen N.V., Human Longevity, Inc., Roper Technologies, Inc., and Gene42, Inc., among others, are some of the key players operating in the global market.
Please note: This is not an exhaustive list of companies profiled in the report.
In November 2023, Fabric Genomics announced a strategic collaboration with cloud-based data management pioneer DNAnexus to empower hospitals, clinical laboratories, and academic centers to rapidly access and analyze large-scale clinical whole genome data and bring vital clinical insights to patients.
In April 2024, SOPHiA GENETICS announced a strategic partnership with Strand Life Sciences, a pioneer in bioinformatics and diagnostics, to deliver innovative solutions that will fuel the use of precision medicine globally. The new partnership will leverage the industry-leading strengths of both companies to provide access to advanced genomics technologies, cutting-edge bioinformatics services, and innovative diagnostics solutions.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 GLOBAL PRECISION MEDICINE SOFTWARE MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL PRECISION MEDICINE SOFTWARE MARKET, BY DELIVERY MODE
4.1 Introduction
4.2 Precision Medicine Software Market: Delivery Mode Scope Key Takeaways
4.3 Revenue Growth Analysis, 2023 & 2029
4.4 Cloud-based
4.4.1 Cloud-based Market Estimates and Forecast, 2021-2029 (USD Million)
4.5 On-premise
4.5.1 On-premise Market Estimates and Forecast, 2021-2029 (USD Million)
5 GLOBAL PRECISION MEDICINE SOFTWARE MARKET, BY APPLICATION
5.1 Introduction
5.2 Precision Medicine Software Market: Application Scope Key Takeaways
5.3 Revenue Growth Analysis, 2023 & 2029
5.4 Oncology
5.4.1 Oncology Market Estimates and Forecast, 2021-2029 (USD Million)
5.5 Pharmacogenomics
5.5.1 Pharmacogenomics Market Estimates and Forecast, 2021-2029 (USD Million)
5.6 Rare Diseases
5.6.1 Rare Diseases Market Estimates and Forecast, 2021-2029 (USD Million)
5.7 Others
5.7.1 Others Market Estimates and Forecast, 2021-2029 (USD Million)
6 GLOBAL PRECISION MEDICINE SOFTWARE MARKET, BY END USER
6.1 Introduction
6.2 Precision Medicine Software Market: End User Scope Key Takeaways
6.3 Revenue Growth Analysis, 2023 & 2029
6.4 Healthcare Providers
6.4.1 Healthcare Providers Market Estimates and Forecast, 2021-2029 (USD Million)
6.5 Research Centers & Government Institutes
6.5.1 Research Centers & Government Institutes Market Estimates and Forecast, 2021-2029 (USD Million)
6.6 Pharmaceutical & Biotechnology Companies
6.6.1 Pharmaceutical & Biotechnology Companies Market Estimates and Forecast, 2021-2029 (USD Million)
7 GLOBAL PRECISION MEDICINE SOFTWARE MARKET, BY REGION
7.1 Introduction
7.2 North America Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.2.1 By Delivery Mode
7.2.2 By Application
7.2.3 By End User
7.2.4 By Country
7.2.4.1 U.S. Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.2.4.1.1 By Delivery Mode
7.2.4.1.2 By Application
7.2.4.1.3 By End User
7.2.4.2 Canada Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.2.4.2.1 By Delivery Mode
7.2.4.2.2 By Application
7.2.4.2.3 By End User
7.2.4.3 Mexico Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.2.4.3.1 By Delivery Mode
7.2.4.3.2 By Application
7.2.4.3.3 By End User
7.3 Europe Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.1 By Delivery Mode
7.3.2 By Application
7.3.3 By End User
7.3.4 By Country
7.3.4.1 Germany Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.1.1 By Delivery Mode
7.3.4.1.2 By Application
7.3.4.1.3 By End User
7.3.4.2 U.K. Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.2.1 By Delivery Mode
7.3.4.2.2 By Application
7.3.4.2.3 By End User
7.3.4.3 France Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.3.1 By Delivery Mode
7.3.4.3.2 By Application
7.3.4.3.3 By End User
7.3.4.4 Italy Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.4.1 By Delivery Mode
7.3.4.4.2 By Application
7.2.4.4.3 By End User
7.3.4.5 Spain Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.5.1 By Delivery Mode
7.3.4.5.2 By Application
7.2.4.5.3 By End User
7.3.4.6 Netherlands Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.6.1 By Delivery Mode
7.3.4.6.2 By Application
7.2.4.6.3 By End User
7.3.4.7 Rest of Europe Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.7.1 By Delivery Mode
7.3.4.7.2 By Application
7.2.4.7.3 By End User
7.4 Asia Pacific Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.1 By Delivery Mode
7.4.2 By Application
7.4.3 By End User
7.4.4 By Country
7.4.4.1 China Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.1.1 By Delivery Mode
7.4.4.1.2 By Application
7.4.4.1.3 By End User
7.4.4.2 Japan Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.2.1 By Delivery Mode
7.4.4.2.2 By Application
7.4.4.2.3 By End User
7.4.4.3 India Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.3.1 By Delivery Mode
7.4.4.3.2 By Application
7.4.4.3.3 By End User
7.4.4.4 South Korea Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.4.1 By Delivery Mode
7.4.4.4.2 By Application
7.4.4.4.3 By End User
7.4.4.5 Singapore Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.5.1 By Delivery Mode
7.4.4.5.2 By Application
7.4.4.5.3 By End User
7.4.4.6 Malaysia Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.6.1 By Delivery Mode
7.4.4.6.2 By Application
7.4.4.6.3 By End User
7.4.4.7 Thailand Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.7.1 By Delivery Mode
7.4.4.7.2 By Application
7.4.4.7.3 By End User
7.4.4.8 Indonesia Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.8.1 By Delivery Mode
7.4.4.8.2 By Application
7.4.4.8.3 By End User
7.4.4.9 Vietnam Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.9.1 By Delivery Mode
7.4.4.9.2 By Application
7.4.4.9.3 By End User
7.4.4.10 Taiwan Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.10.1 By Delivery Mode
7.4.4.10.2 By Application
7.4.4.10.3 By End User
7.4.4.11 Rest of Asia Pacific Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.11.1 By Delivery Mode
7.4.4.11.2 By Application
7.4.4.11.3 By End User
7.5 Middle East and Africa Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.1 By Delivery Mode
7.5.2 By Application
7.5.3 By End User
7.5.4 By Country
7.5.4.1 Saudi Arabia Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.4.1.1 By Delivery Mode
7.5.4.1.2 By Application
7.5.4.1.3 By End User
7.5.4.2 U.A.E. Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.4.2.1 By Delivery Mode
7.5.4.2.2 By Application
7.5.4.2.3 By End User
7.5.4.3 Israel Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.4.3.1 By Delivery Mode
7.5.4.3.2 By Application
7.5.4.3.3 By End User
7.5.4.4 South Africa Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.4.4.1 By Delivery Mode
7.5.4.4.2 By Application
7.5.4.4.3 By End User
7.5.4.5 Rest of Middle East and Africa Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.4.5.1 By Delivery Mode
7.5.4.5.2 By Application
7.5.4.5.2 By End User
7.6 Central & South America Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.6.1 By Delivery Mode
7.6.2 By Application
7.6.3 By End User
7.6.4 By Country
7.6.4.1 Brazil Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.6.4.1.1 By Delivery Mode
7.6.4.1.2 By Application
7.6.4.1.3 By End User
7.6.4.2 Argentina Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.6.4.2.1 By Delivery Mode
7.6.4.2.2 By Application
7.6.4.2.3 By End User
7.6.4.3 Chile Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.6.4.3.1 By Delivery Mode
7.6.4.3.2 By Application
7.6.4.3.3 By End User
7.6.4.4 Rest of Central & South America Precision Medicine Software Market Estimates and Forecast, 2021-2029 (USD Million)
7.6.4.4.1 By Delivery Mode
7.6.4.4.2 By Application
7.6.4.4.3 By End User
8 COMPETITIVE LANDCAPE
8.1 Company Market Share Analysis
8.2 Four Quadrant Positioning Matrix
8.2.1 Market Leaders
8.2.2 Market Visionaries
8.2.3 Market Challengers
8.2.4 Niche Market Players
8.3 Vendor Landscape
8.3.1 North America
8.3.2 Europe
8.3.3 Asia Pacific
8.3.4 Rest of the World
8.4 Company Profiles
8.4.1 Synapse, Inc.
8.4.1.1 Business Description & Financial Analysis
8.4.1.2 SWOT Analysis
8.4.1.3 Products & Services Offered
8.4.1.4 Strategic Alliances between Business Partners
8.4.2 Allscripts Healthcare Solutions, Inc.,
8.4.2.1 Business Description & Financial Analysis
8.4.2.2 SWOT Analysis
8.4.2.3 Products & Services Offered
8.4.2.4 Strategic Alliances between Business Partners
8.4.3 Roche Holdings, Inc.
8.4.3.1 Business Description & Financial Analysis
8.4.3.2 SWOT Analysis
8.4.3.3 Products & Services Offered
8.4.3.4 Strategic Alliances between Business Partners
8.4.4 Fabric Genomics, Inc.
8.4.4.1 Business Description & Financial Analysis
8.4.4.2 SWOT Analysis
8.4.4.3 Products & Services Offered
8.4.4.4 Strategic Alliances between Business Partners
8.4.5 Sophia Genetics SA
8.4.5.1 Business Description & Financial Analysis
8.4.5.2 SWOT Analysis
8.4.5.3 Products & Services Offered
8.4.5.4 Strategic Alliances between Business Partners
8.4.6 PIERIANDX, INC.
8.4.6.1 Business Description & Financial Analysis
8.4.6.2 SWOT Analysis
8.4.6.3 Products & Services Offered
8.4.6.4 Strategic Alliances between Business Partners
8.4.7 Qiagen N.V.
8.4.7.1 Business Description & Financial Analysis
8.4.7.2 SWOT Analysis
8.4.7.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.8 Human Longevity
8.4.8.1 Business Description & Financial Analysis
8.4.8.2 SWOT Analysis
8.4.8.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.9 ROPER TECHNOLOGIES, INC.
8.4.9.1 Business Description & Financial Analysis
8.4.9.2 SWOT Analysis
8.4.9.3 Products & Services Offered
8.4.9.4 Strategic Alliances between Business Partners
8.4.10 Gene42, Inc.
8.4.10.1 Business Description & Financial Analysis
8.4.10.2 SWOT Analysis
8.4.10.3 Products & Services Offered
8.4.10.4 Strategic Alliances between Business Partners
8.4.11 Other Companies
8.4.11.1 Business Description & Financial Analysis
8.4.11.2 SWOT Analysis
8.4.11.3 Products & Services Offered
8.4.11.4 Strategic Alliances between Business Partners
9 RESEARCH METHODOLOGY
9.1 Market Introduction
9.1.1 Market Definition
9.1.2 Market Scope & Segmentation
9.2 Information Procurement
9.2.1 Secondary Research
9.2.1.1 Purchased Databases
9.2.1.2 GMEs Internal Data Repository
9.2.1.3 Secondary Resources & Third Party Perspectives
9.2.1.4 Company Information Sources
9.2.2 Primary Research
9.2.2.1 Various Types of Respondents for Primary Interviews
9.2.2.2 Number of Interviews Conducted throughout the Research Process
9.2.2.3 Primary Stakeholders
9.2.2.4 Discussion Guide for Primary Participants
9.2.3 Expert Panels
9.2.3.1 Expert Panels Across 30+ Industry
9.2.4 Paid Local Experts
9.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
9.3 Market Estimation
9.3.1 Top-Down Approach
9.3.1.1 Macro-Economic Indicators Considered
9.3.1.2 Micro-Economic Indicators Considered
9.3.2 Bottom Up Approach
9.3.2.1 Company Share Analysis Approach
9.3.2.2 Estimation of Potential Product Sales
9.4 Data Triangulation
9.4.1 Data Collection
9.4.2 Time Series, Cross Sectional & Panel Data Analysis
9.4.3 Cluster Analysis
9.5 Analysis and Output
9.5.1 Inhouse AI Based Real Time Analytics Tool
9.5.2 Output From Desk & Primary Research
9.6 Research Assumptions & Limitations
9.7.1 Research Assumptions
9.7.2 Research Limitations
LIST OF TABLES
1 Global Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
2 Cloud-based Market, By Region, 2021-2029 (USD Million)
3 On-premise Market, By Region, 2021-2029 (USD Million)
4 Global Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
5 Oncology Market, By Region, 2021-2029 (USD Million)
6 Pharmacogenomics Market, By Region, 2021-2029 (USD Million)
7 Rare Diseases Market, By Region, 2021-2029 (USD Million)
8 Others Market, By Region, 2021-2029 (USD Million)
9 Global Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
10 Healthcare Providers Market, By Region, 2021-2029 (USD Million)
11 RESEARCH CENTERS & GOVERNMENT INSTITUTES Market, By Region, 2021-2029 (USD Million)
12 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES Market, By Region, 2021-2029 (USD Million)
13 Regional Analysis, 2021-2029 (USD Million)
14 North America Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
15 North America Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
16 North America Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
17 North America Precision Medicine Software Market, By Country, 2021-2029 (USD Million)
18 U.S. Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
19 U.S. Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
20 U.S. Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
21 Canada Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
22 Canada Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
23 Canada Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
24 Mexico Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
25 Mexico Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
26 Mexico Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
27 Europe Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
28 Europe Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
29 Europe Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
30 Europe Precision Medicine Software Market, By COUNTRY, 2021-2029 (USD Million)
31 Germany Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
32 Germany Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
33 Germany Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
34 UK Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
35 UK Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
36 UK Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
37 France Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
38 France Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
39 France Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
40 Italy Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
41 Italy Precision Medicine Software Market, By T End Use Type, 2021-2029 (USD Million)
42 Italy Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
43 Spain Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
44 Spain Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
45 Spain Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
46 Rest Of Europe Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
47 Rest Of Europe Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
48 Rest of Europe Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
49 Asia Pacific Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
50 Asia Pacific Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
51 Asia Pacific Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
52 Asia Pacific Precision Medicine Software Market, By Country, 2021-2029 (USD Million)
53 China Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
54 China Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
55 China Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
56 India Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
57 India Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
58 India Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
59 Japan Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
60 Japan Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
61 Japan Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
62 South Korea Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
63 South Korea Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
64 South Korea Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
65 Malaysia Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
66 Malaysia Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
67 Malaysia Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
68 Vietnam Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
69 Vietnam Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
70 Vietnam Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
71 Rest of Asia Pacific Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
72 Rest of Asia Pacific Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
73 Rest of Asia Pacific Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
74 Middle East and Africa Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
75 Middle East and Africa Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
76 Middle East and Africa Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
77 Middle East and Africa Precision Medicine Software Market, By Country, 2021-2029 (USD Million)
78 Saudi Arabia Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
79 Saudi Arabia Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
80 Saudi Arabia Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
81 UAE Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
82 UAE Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
83 UAE Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
84 Rest of Middle East and Africa Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
85 Rest of Middle East and Africa Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
86 Rest of Middle East and Africa Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
87 Central & South America Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
88 Central & South America Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
89 Central & South America Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
90 Central & South America Precision Medicine Software Market, By Country, 2021-2029 (USD Million)
91 Brazil Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
92 Brazil Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
93 Brazil Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
94 Argentina Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
95 Argentina Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
96 Argentina Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
97 Rest of Central & South America Precision Medicine Software Market, By Delivery Mode, 2021-2029 (USD Million)
98 Rest of Central & South America Precision Medicine Software Market, By Application, 2021-2029 (USD Million)
99 Rest of Central & South America Precision Medicine Software Market, By End User, 2021-2029 (USD Million)
100 Synapse, Inc.: Products & Services Offering
101 Allscripts Healthcare Solutions, Inc., : Products & Services Offering
102 Roche Holdings, Inc.: Products & Services Offering
103 Fabric Genomics, Inc.: Products & Services Offering
104 Sophia Genetics SA: Products & Services Offering
105 PIERIANDX, INC.: Products & Services Offering
106 Qiagen N.V.: Products & Services Offering
107 Human Longevity: Products & Services Offering
108 ROPER TECHNOLOGIES, INC.: Products & Services Offering
109 Gene42, Inc.: Products & Services Offering
110 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Precision Medicine Software Market Overview
2 Global Precision Medicine Software Market Value From 2021-2029 (USD Million)
3 Global Precision Medicine Software Market Share, By Delivery Mode (2023)
4 Global Precision Medicine Software Market Share, By Application (2023)
5 Global Precision Medicine Software Market Share, By End User (2023)
6 Global Precision Medicine Software Market, By Region (Asia Pacific Market)
7 Technological Trends In Global Precision Medicine Software Market
8 Four Quadrant Competitor Positioning Matrix
9 Impact Of Macro & Micro Indicators On The Market
10 Impact Of Key Drivers On The Global Precision Medicine Software Market
11 Impact Of Challenges On The Global Precision Medicine Software Market
12 Porter’s Five Forces Analysis
13 Global Precision Medicine Software Market: By Delivery Mode Scope Key Takeaways
14 Global Precision Medicine Software Market, By Delivery Mode Segment: Revenue Growth Analysis
15 Cloud-based Market, By Region, 2021-2029 (USD Million)
16 On-premise Market, By Region, 2021-2029 (USD Million)
17 Global Precision Medicine Software Market: By Application Scope Key Takeaways
18 Global Precision Medicine Software Market, By Application Segment: Revenue Growth Analysis
19 Oncology Market, By Region, 2021-2029 (USD Million)
20 Pharmacogenomics Market, By Region, 2021-2029 (USD Million)
21 Rare Diseases Market, By Region, 2021-2029 (USD Million)
22 Others Market, By Region, 2021-2029 (USD Million)
23 Global Precision Medicine Software Market: By End User Scope Key Takeaways
24 Global Precision Medicine Software Market, By End User Segment: Revenue Growth Analysis
25 Healthcare Providers Market, By Region, 2021-2029 (USD Million)
26 Research Centers & Government Institutes Market, By Region, 2021-2029 (USD Million)
27 Pharmaceutical & Biotechnology Companies Market, By Region, 2021-2029 (USD Million)
28 Regional Segment: Revenue Growth Analysis
29 Global Precision Medicine Software Market: Regional Analysis
30 North America Precision Medicine Software Market Overview
31 North America Precision Medicine Software Market, By Delivery Mode
32 North America Precision Medicine Software Market, By Application
33 North America Precision Medicine Software Market, By End User
34 North America Precision Medicine Software Market, By Country
35 U.S. Precision Medicine Software Market, By Delivery Mode
36 U.S. Precision Medicine Software Market, By Application
37 U.S. Precision Medicine Software Market, By End User
38 Canada Precision Medicine Software Market, By Delivery Mode
39 Canada Precision Medicine Software Market, By Application
40 Canada Precision Medicine Software Market, By End User
41 Mexico Precision Medicine Software Market, By Delivery Mode
42 Mexico Precision Medicine Software Market, By Application
43 Mexico Precision Medicine Software Market, By End User
44 Four Quadrant Positioning Matrix
45 Company Market Share Analysis
46 Synapse, Inc.: Company Snapshot
47 Synapse, Inc.: SWOT Analysis
48 Synapse, Inc.: Geographic Presence
49 Allscripts Healthcare Solutions, Inc., : Company Snapshot
50 Allscripts Healthcare Solutions, Inc., : SWOT Analysis
51 Allscripts Healthcare Solutions, Inc., : Geographic Presence
52 Roche Holdings, Inc.: Company Snapshot
53 Roche Holdings, Inc.: SWOT Analysis
54 Roche Holdings, Inc.: Geographic Presence
55 Fabric Genomics, Inc.: Company Snapshot
56 Fabric Genomics, Inc.: Swot Analysis
57 Fabric Genomics, Inc.: Geographic Presence
58 Sophia Genetics SA: Company Snapshot
59 Sophia Genetics SA: SWOT Analysis
60 Sophia Genetics SA: Geographic Presence
61 PIERIANDX, INC.: Company Snapshot
62 PIERIANDX, INC.: SWOT Analysis
63 PIERIANDX, INC.: Geographic Presence
64 Qiagen N.V.: Company Snapshot
65 Qiagen N.V.: SWOT Analysis
66 Qiagen N.V.: Geographic Presence
67 Human Longevity: Company Snapshot
68 Human Longevity: SWOT Analysis
69 Human Longevity: Geographic Presence
70 ROPER TECHNOLOGIES, INC..: Company Snapshot
71 ROPER TECHNOLOGIES, INC..: SWOT Analysis
72 ROPER TECHNOLOGIES, INC..: Geographic Presence
73 Gene42, Inc.: Company Snapshot
74 Gene42, Inc.: SWOT Analysis
75 Gene42, Inc.: Geographic Presence
76 Other Companies: Company Snapshot
77 Other Companies: SWOT Analysis
78 Other Companies: Geographic Presence
The Global Precision Medicine Software Market has been studied from the year 2019 till 2029. However, the CAGR provided in the report is from the year 2024 to 2029. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Precision Medicine Software Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
